Pulse Biosciences, Inc. 8-K Report: Key Insights & Filing Details

$PLSE
Form 8-K
Filed on: 2024-12-26
Source
Pulse Biosciences, Inc. 8-K Report: Key Insights & Filing Details

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Pulse Biosciences, Inc.
  • CIK Number: 0001625101
  • Central Index Key (SEC): 001-37744
  • EIN: 46-5696597
  • Address: 601 Brickell Key Drive, Suite 1080, Miami, FL 33131
  • Phone Number: 510-906-4600
  1. Filing Details:
  • Filing Type: 8-K (a form used to report major events that shareholders should know about)
  • Filing Date: December 23, 2024
  1. Stock Information:
  • Common Stock Ticker Symbol: PLSE
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: December 23, 2024
  • End Date: December 23, 2024
  1. XBRL Information:
  • The report is structured in XBRL format, indicating it is intended for digital filing and analysis.

This information provides a snapshot of Pulse Biosciences, Inc.'s SEC filing, which is crucial for investors, analysts, and stakeholders to assess the company's current status and any significant events reported on that date.